TrumpRx at 6 months: Has the drug-pricing experiment delivered?

Six months after President Trump's TrumpRx initiative launched, the federal direct-to-consumer drug discount website now offers 92 branded drugs and over 600 generics. While it has expanded its catalog, it still only covers less than 12% of the available brand-name medications. This development is significant as it reflects the ongoing efforts to tackle high drug prices in the U.S., offering some consumers discounts but leaving many questions about broader drug pricing reform unanswered. The initiative's limited reach and impact thus far underscore the challenges in addressing pharmaceutical pricing issues.